( NASDAQ-NMS:ARRY )

News from array biopharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 06, 2016, 14:15 ET Array Presents Full Results from Phase 3 NEMO Study

 Array BioPharma (Nasdaq: ARRY) announced full results at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago...


Jun 04, 2016, 09:00 ET Array BioPharma, Pierre Fabre and Merck KGaA, Darmstadt, Germany Announce Phase 3 BEACON CRC Trial

 Array BioPharma (Nasdaq: ARRY), Pierre Fabre and Merck KGaA, Darmstadt, Germany, today jointly initiated the BEACON CRC (Binimetinib,...


Jun 04, 2016, 09:00 ET Encorafenib-based Regimens Provide Improved PFS and OS in Difficult-to-Treat BRAF-Mutant Colorectal Cancer Compared to Historical Benchmarks

 Array BioPharma (Nasdaq: ARRY) announced today updated results from a Phase 2 study of the combination of encorafenib and cetuximab, with or...


Jun 02, 2016, 14:20 ET Array BioPharma To Present At The Jefferies 2016 Global Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Jefferies 2016 Global...


May 18, 2016, 17:05 ET Array BioPharma Announces Key Data from NRAS-mutant Melanoma and BRAF-mutant Colorectal Cancer ASCO 2016 Presentations

 Array BioPharma (NASDAQ: ARRY) will present additional data on its late-stage candidates binimetinib and encorafenib in NRAS-mutant melanoma...


May 05, 2016, 19:00 ET Array BioPharma To Present At The Bank of America Merrill Lynch HealthCare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill...


May 03, 2016, 08:00 ET Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2016

 Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small...


Apr 26, 2016, 12:25 ET Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2016 On May 3, 2016

 Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2016 and hold a conference call to...


Apr 01, 2016, 09:00 ET Array BioPharma Announces Decision To Discontinue MILO Study In Ovarian Cancer

Array BioPharma Inc. (Nasdaq: ARRY) announced today its decision to discontinue the MILO study, a Phase 3 trial of binimetinib for the treatment of...


Mar 31, 2016, 09:00 ET Array BioPharma And Asahi Kasei Pharma Corporation Announce Development And Commercialization Collaboration For Novel Pain And Inflammation Program

 Array BioPharma Inc. (Nasdaq: ARRY) and Asahi Kasei Pharma Corporation today announced a strategic collaboration to develop and...


Mar 01, 2016, 12:53 ET Array BioPharma To Present At The Cowen And Company Annual Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cowen and Company Annual...


Feb 02, 2016, 12:00 ET Array BioPharma To Present At The Leerink Partners Annual Global Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Partners Annual...


Feb 02, 2016, 07:00 ET Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2016

 Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the second quarter ending December 31, 2015 of its fiscal year and provided an...


Feb 01, 2016, 11:56 ET Dana-Farber Cancer Institute's Belfer Center announces Immuno-Oncology research collaboration with Array BioPharma

Dana-Farber Cancer Institute today announced an immuno-oncology collaboration with potential applicability in a wide range of oncology indications...


Jan 26, 2016, 14:32 ET Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2016 On February 2, 2016

Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the second quarter of fiscal 2016 and hold a conference call to discuss...


Jan 06, 2016, 10:00 ET Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare...


Dec 21, 2015, 07:00 ET Array Announces Closing Of Pierre Fabre Transaction

Array BioPharma Inc. (NASDAQ: ARRY) today announced the closing of its definitive agreement with Pierre Fabre following approval of the...


Dec 16, 2015, 06:30 ET Array BioPharma Announces Phase 3 Binimetinib Trial Meets Primary Endpoint For NRAS-Mutant Melanoma

 Array BioPharma (Nasdaq: ARRY) today reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with...


Dec 01, 2015, 13:21 ET Array BioPharma To Present At The Oppenheimer Annual Healthcare Conference

Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Oppenheimer Annual...


Nov 24, 2015, 15:59 ET Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Piper Jaffray Annual...


Nov 16, 2015, 07:30 ET Array BioPharma And Pierre Fabre Announce Development And Commercialization Collaboration For Two Novel Oncology Products, Binimetinib And Encorafenib

Array BioPharma Inc. (Nasdaq: ARRY) and Pierre Fabre today announced a collaboration to globally develop and commercialize Array's late-stage...


Nov 09, 2015, 17:23 ET Array BioPharma To Present At The Stifel 2015 Healthcare And Jefferies 2015 Global Healthcare Conferences

 Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming...


Nov 04, 2015, 08:00 ET Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2016

 Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the first quarter of its fiscal year ending June 30, 2016 and provided an...


Oct 26, 2015, 16:11 ET Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2016 On November 4, 2015

Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the first quarter of fiscal 2016 and hold a conference call to discuss...


Sep 28, 2015, 07:00 ET Clinical Data Presented On Binimetinib And Encorafenib In Melanoma

 Clinical trial results from Array BioPharma's (Nasdaq:  ARRY) wholly-owned MEK inhibitor, binimetinib, and BRAF inhibitor, encorafenib,...